Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 371,441 | 400,014 | +28,573 | $38.00M | $31.31M | 7.00% | -$6.69M |
| Merus N V | 635,439 | 680,845 | +45,406 | $31.75M | $28.63M | 6.40% | -$3.12M |
| Insmed Incorporated(INSM) | 347,695 | 372,230 | +24,535 | $25.38M | $25.70M | 5.75% | +$317.0K |
| Verona Pharma PlcADS | 348,866 | 516,014 | +167,148 | $10.04M | $23.96M | 5.36% | +$13.93M |
| Akero Therapeutics Inc | 639,840 | 739,563 | +99,723 | $18.36M | $20.57M | 4.60% | +$2.22M |
| Veracyte, Inc.(VCYT) | 470,565 | 503,281 | +32,716 | $16.02M | $19.93M | 4.46% | +$3.91M |
| Erasca, Inc.(ERAS) | 6,946,488 | 7,543,901 | +597,413 | $18.96M | $18.94M | 4.23% | -$28.7K |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 1,315,601 | +1,315,601 | $0 | $17.33M | 3.87% | +$17.33M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 378,746 | 1,230,400 | +851,654 | $7.29M | $16.27M | 3.64% | +$8.98M |
| Avidity Biosciences Inc | 475,555 | 543,651 | +68,096 | $21.84M | $15.81M | 3.54% | -$6.03M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 255,578 | 273,896 | +18,318 | $13.39M | $15.33M | 3.43% | +$1.94M |
| Intra-Cellular Therapies Inc | 167,110 | 179,085 | +11,975 | $12.23M | $14.96M | 3.34% | +$2.73M |
| UroGen Pharma Ltd.(URGN) | 901,129 | 1,120,473 | +219,344 | $11.44M | $11.93M | 2.67% | +$488.7K |
| Centessa Pharmaceuticals PlcADS | 744,592 | 598,952 | -145,640 | $11.91M | $10.03M | 2.24% | -$1.87M |
| Kodiak Sciences Inc.(KOD) | 500,000 | 1,000,000 | +500,000 | $1.30M | $9.95M | 2.22% | +$8.64M |
| Poseida Therapeutics Inc | 3,687,548 | 1,012,307 | -2,675,241 | $10.55M | $9.72M | 2.17% | -$828.2K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,099,490 | 1,178,300 | +78,810 | $11.27M | $9.51M | 2.13% | -$1.76M |
| TELA Bio, Inc.(TELA) | 1,124,928 | 3,065,649 | +1,940,721 | $2.85M | $9.26M | 2.07% | +$6.41M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 183,243 | +183,243 | $0 | $7.92M | 1.77% | +$7.92M |
| Wave Life Sciences, Inc.SHS(WVE) | 627,552 | 608,897 | -18,655 | $5.15M | $7.53M | 1.68% | +$2.39M |
| Cogent Biosciences, Inc.(COGT) | 1,221,362 | 921,137 | -300,225 | $13.19M | $7.18M | 1.61% | -$6.01M |
| Ascendis Pharma A/SADR(ASND) | 5,000 | 51,491 | +46,491 | $746.5K | $7.09M | 1.59% | +$6.34M |
| Disc Medicine, Inc.(IRON) | 103,862 | 110,381 | +6,519 | $5.10M | $7.00M | 1.56% | +$1.89M |
| Celldex Therapeutics, Inc.(CLDX) | 145,000 | 264,560 | +119,560 | $4.93M | $6.69M | 1.49% | +$1.76M |
| Elutia Inc.CL A(ELUT) | 1,645,808 | 1,782,271 | +136,463 | $6.27M | $6.67M | 1.49% | +$395.2K |
| Biodesix, Inc.(BDSX) | 3,561,094 | 4,332,281 | +771,187 | $6.34M | $6.63M | 1.48% | +$289.6K |
| Gossamer Bio, Inc.(GOSS) | 5,645,352 | 6,171,847 | +526,495 | $5.57M | $5.58M | 1.25% | +$14.5K |
| Praxis Precision Medicines, Inc.(PRAX) | 67,045 | 72,516 | +5,471 | $3.86M | $5.58M | 1.25% | +$1.72M |
| Helix Acquisition Corp IiCL A | 513,369 | 513,369 | 0 | $5.36M | $5.39M | 1.21% | +$25.7K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 124,388 | +124,388 | $0 | $5.23M | 1.17% | +$5.23M |
| Kalvista Pharmaceuticals Inc | 574,558 | 612,173 | +37,615 | $6.65M | $5.19M | 1.16% | -$1.47M |
| Travere Therapeutics, Inc.(TVTX) | 0 | 277,365 | +277,365 | $0 | $4.83M | 1.08% | +$4.83M |
| C4 Therapeutics, Inc.(CCCC) | 1,147,891 | 1,221,131 | +73,240 | $6.54M | $4.40M | 0.98% | -$2.15M |
| Structure Therapeutics IncADS | 70,516 | 152,395 | +81,879 | $3.09M | $4.13M | 0.92% | +$1.04M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 40,000 | 65,955 | +25,955 | $1.32M | $3.65M | 0.82% | +$2.34M |
| Incyte Corporation(INCY) | 0 | 49,000 | +49,000 | $0 | $3.38M | 0.76% | +$3.38M |
| Vaxcyte, Inc.(PCVX) | 60,500 | 40,788 | -19,712 | $6.91M | $3.34M | 0.75% | -$3.57M |
| Geron Corporation(GERN) | 1,801,561 | 920,022 | -881,539 | $8.18M | $3.26M | 0.73% | -$4.92M |
| Trevi Therapeutics, Inc.(TRVI) | 482,575 | 734,234 | +251,659 | $1.61M | $3.03M | 0.68% | +$1.41M |
| Compugen Ltd.(CGEN) | 1,501,113 | 1,624,377 | +123,264 | $2.72M | $2.49M | 0.56% | -$231.7K |
| Cerus Corporation(CERS) | 1,495,329 | 1,587,228 | +91,899 | $2.60M | $2.44M | 0.55% | -$157.5K |
| ABIVAX Société AnonymeADS(ABVX) | 461,660 | 285,120 | -176,540 | $5.32M | $2.09M | 0.47% | -$3.23M |
| Unicycive Therapeutics Inc | 4,000,000 | 2,486,709 | -1,513,291 | $1.63M | $1.97M | 0.44% | +$343.3K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 100,000 | +100,000 | $0 | $1.92M | 0.43% | +$1.92M |
| Delcath Systems, Inc.(DCTH) | 0 | 155,325 | +155,325 | $0 | $1.87M | 0.42% | +$1.87M |
| uniQure N.V.SHS(QURE) | 0 | 100,000 | +100,000 | $0 | $1.77M | 0.39% | +$1.77M |
| Modular Med Inc | 1,440,000 | 1,272,015 | -167,985 | $3.24M | $1.74M | 0.39% | -$1.50M |
| KALA BIO, Inc.(KALA) | 0 | 231,070 | +231,070 | $0 | $1.60M | 0.36% | +$1.60M |
| Olema Pharmaceuticals, Inc.(OLMA) | 455,082 | 233,281 | -221,801 | $5.43M | $1.36M | 0.30% | -$4.07M |
| Gilead Sciences, Inc.(GILD) | 0 | 10,000 | +10,000 | $0 | $923.7K | 0.21% | +$923.7K |
| EyePoint, Inc.(EYPT) | 100,000 | 121,274 | +21,274 | $799.0K | $903.5K | 0.20% | +$104.5K |
| Radiopharm Theranostics LimitedADS(RADX) | 0 | 187,406 | +187,406 | $0 | $841.5K | 0.19% | +$841.5K |
| 89bio Inc | 92,298 | 96,511 | +4,213 | $683.0K | $754.7K | 0.17% | +$71.7K |
| Vaxart, Inc.(VXRT) | 1,000,000 | 1,077,782 | +77,782 | $849.0K | $713.6K | 0.16% | -$135.4K |
| Karyopharm Therapeutics Inc.(KPTI) | 558,466 | 595,990 | +37,524 | $463.5K | $403.1K | 0.09% | -$60.5K |
| Fractyl Health, Inc.(GUTS) | 166,666 | 176,922 | +10,256 | $421.7K | $364.5K | 0.08% | -$57.2K |
| BioAge Labs, Inc.(BIOA) | 100,000 | 39,974 | -60,026 | $2.08M | $231.4K | 0.05% | -$1.85M |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 104,828 | 104,828 | 0 | $6.8K | $3.6K | 0.00% | -$3.2K |
| ADC Therapeutics SASHS(ADCT) | 1,795,080 | 0 | -1,795,080 | $5.65M | $0 | — | -$5.65M |
| Aligos Therapeutics, Inc.(ALGS) | 26,219 | 0 | -26,219 | $227.1K | $0 | — | -$227.1K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 35,774 | 0 | -35,774 | $9.84M | $0 | — | -$9.84M |
| Applied Therapeutics Inc | 100,000 | 0 | -100,000 | $850.0K | $0 | — | -$850.0K |
| Biogen Inc.(BIIB) | 19,940 | 0 | -19,940 | $3.87M | $0 | — | -$3.87M |
| Biohaven Ltd.(BHVN) | 99,566 | 0 | -99,566 | $4.98M | $0 | — | -$4.98M |
| BioNTech SEADS(BNTX) | 26,083 | 0 | -26,083 | $3.10M | $0 | — | -$3.10M |
| Black Diamond Therapeutics I | 100,000 | 0 | -100,000 | $435.0K | $0 | — | -$435.0K |
| Evogene Ltd.SHS NEW(EVGN) | 307,974 | 0 | -307,974 | $945.5K | $0 | — | -$945.5K |
| Instil Bio, Inc.(TIL) | 10,517 | 0 | -10,517 | $708.0K | $0 | — | -$708.0K |
| Longboard Pharmaceuticals In | 124,353 | 0 | -124,353 | $4.14M | $0 | — | -$4.14M |
| Mersana Therapeutics Inc | 1,585,786 | 0 | -1,585,786 | $3.00M | $0 | — | -$3.00M |
| Molecular Templates Inc | 623,838 | 0 | -623,838 | $876.5K | $0 | — | -$876.5K |
| Perspective Therapeutics, Inc.(CATX) | 167,986 | 0 | -167,986 | $2.24M | $0 | — | -$2.24M |
| Protagonist Therapeutics Inc | 146,657 | 0 | -146,657 | $6.60M | $0 | — | -$6.60M |
| Relay Therapeutics, Inc.(RLAY) | 419,242 | 0 | -419,242 | $2.97M | $0 | — | -$2.97M |
| Sarepta Therapeutics, Inc.(SRPT) | 51,245 | 0 | -51,245 | $6.40M | $0 | — | -$6.40M |
| Solid Biosciences Inc | 457,739 | 0 | -457,739 | $3.19M | $0 | — | -$3.19M |
| Yarrow Bioscience Inc(YARW) | 76,784 | 0 | -76,784 | $144.4K | $0 | — | -$144.4K |
| Xencor, Inc.(XNCR) | 75,507 | 0 | -75,507 | $1.52M | $0 | — | -$1.52M |
| Zevra Therapeutics, Inc.(ZVRA) | 350,000 | 0 | -350,000 | $2.43M | $0 | — | -$2.43M |